Drug class
Fibric Acid Derivatives
Fibric acid derivatives, commonly referred to as fibrates, are a class of lipid-lowering medications that include agents such as gemfibrozil and fenofibrate. Read more about Fibric Acid Derivatives
86 drugs in this class 57 manufacturers
Drugs in Fibric Acid Derivatives
LOPID (gemfibrozil)
FENOFIBRATE (fenofibrate,micronized)
FENOFIBRATE
GEMFIBROZIL
GEMFIBROZIL
FENOFIBRATE
FENOFIBRATE (fenofibrate,micronized)
FENOFIBRATE (fenofibrate nanocrystallized)
Fibric acid derivatives, commonly referred to as fibrates, are a class of lipid-lowering medications that include agents such as gemfibrozil and fenofibrate.
They function primarily as agonists of the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha), which alters the transcription of genes regulating lipoprotein metabolism, enhances lipoprotein lipase activity, stimulates cellular fatty acid beta-oxidation, and substantially decreases circulating plasma triglycerides while modestly increasing high-density lipoprotein cholesterol.
Clinically, these agents are primarily indicated as adjuncts to diet for the treatment of severe hypertriglyceridemia—often to reduce the risk of acute pancreatitis—and are also utilized in the management of mixed dyslipidemia and primary hypercholesterolemia.
-
nih.gov
Fibric acid derivatives, commonly referred to as fibrates, are a class of lipid-lowering medications that include agents such as gemfibrozil and fenofibrate Clinically, these agents are primarily indicated as adjuncts to diet for the treatment of severe hypertriglyceridemia—often to reduce the risk of acute pancreatitis—and are also utilized in the management of mixed dyslipidemia and primary hypercholesterolemia
-
nih.gov
Fibric acid derivatives, commonly referred to as fibrates, are a class of lipid-lowering medications that include agents such as gemfibrozil and fenofibrate
-
fda.gov
They function primarily as agonists of the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha), which alters the transcription of genes regulating lipoprotein metabolism, enhances lipoprotein lipase activity, stimulates cellular fatty acid beta-oxidation, and substantially decreases circulating plasma triglycerides while modestly increasing high-density lipoprotein cholesterol Clinically, these agents are primarily indicated as adjuncts to diet for the treatment of sev...
-
nih.gov
They function primarily as agonists of the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha), which alters the transcription of genes regulating lipoprotein metabolism, enhances lipoprotein lipase activity, stimulates cellular fatty acid beta-oxidation, and substantially decreases circulating plasma triglycerides while modestly increasing high-density lipoprotein cholesterol
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.